SCHEMBL20745951

SCHEMBL20745951

COc1cc(C)c(-c2ncc3sccc3c2Cl)c(C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
CRHR1 P34998 1/20 0.34
MAPT P10636 3/20 0.33
PPARG P37231 2/20 0.33
HTT P42858 2/20 0.33
NCOA2 Q15596 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
NCOA1 Q15788 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
LMNA P02545 2/20 0.33
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
RAB9A P51151 3/20 0.32
TSHR P16473 2/20 0.32
PRNP P04156 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20745918 0.80 KDM4E (0.38) KDM4EMAPTPPARGHTTNCOA2
SCHEMBL5333350 0.70 KDM4E (0.50) KDM4EMAPTPPARGHTTNCOA2
SCHEMBL3643996 0.70 TUBB4A (0.39) KDM4EMAPTALDH1A1HPGDLMNA
SCHEMBL3648756 0.66 TUBB4A (0.38) KDM4EMAPTPPARGHTTNCOA2
SCHEMBL3783881 0.65 KDM4E (0.46) KDM4EMAPTPPARGHTTNCOA2
SCHEMBL20744991 0.64 KDM4E (0.44) KDM4EMAPTPPARGHTTNCOA2
SCHEMBL3749321 0.61 ALDH1A1 (0.53) KDM4EALDH1A1HPGDTSHRCYP1A2
SCHEMBL18876006 0.61 CYP2A6 (0.42) KDM4EMAPTHTTALDH1A1RAB9A
SCHEMBL12326164 0.61 ALDH1A1 (0.59) ALDH1A1HPGDTSHRKMT2ACYP1A2
SCHEMBL5758557 0.60 MAPT (0.43) KDM4EMAPTALDH1A1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3668504-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE AbbVie Inc. (US) 2020-06-24 EP disclosed
EP-3668502-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE AbbVie Inc. (US) 2020-06-24 EP disclosed
EP-3652184-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE AbbVie Inc. (US) 2020-05-20 EP disclosed
WO-2019035914-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE ABBVIE INC. (US) 2019-02-21 WO disclosed
WO-2019035911-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE ABBVIE INC. (US) 2019-02-21 WO disclosed
WO-2019035927-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE ABBVIE INC. (US) 2019-02-21 WO disclosed